The FDA has authorized a new treatment that may help immunocompromised people be protected from COVID-19. The treatment is a monoclonal antibody infusion that is expected to be available this April.

On March 22, the U.S. Food and Drug Administration, or FDA, issued an emergency use authorization for Pemgarda — a new drug that prevents COVID-19 infection — for certain adults and adolescents, ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...

As new COVID variants rise in the U.S., antibodies are getting wiped off the list of treatments. NPR's Pien Huang explains why these infusion treatments didn't last and how scientists are searching ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

More than 3.5 million infusions of antibodies have been used to treat COVID. The treatment is being phased out because the antibodies have lost their efficacy against new variants of coronavirus. As ...